+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Type 1 Diabetes Market and Competitive Landscape - 2021

  • PDF Icon

    Report

  • January 2021
  • Region: United States
  • Fore Pharma
  • ID: 5236055
The latest research US Type 1 Diabetes Market and Competitive Landscape Highlights - 2021, provides comprehensive insights into Type 1 Diabetes pipeline products, Type 1 Diabetes epidemiology, Type 1 Diabetes market valuations and forecast, Type 1 Diabetes drugs sales and competitive landscape in the US.

The research is classified into seven sections - Type 1 Diabetes treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:
  • Type 1 Diabetes pipeline: Find out the products in clinical trials for the treatment of Type 1 Diabetes by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Type 1 Diabetes epidemiology: Find out the number of patients diagnosed (prevalence) with Type 1 Diabetes in the US
  • Type 1 Diabetes drugs: Identify key products marketed and prescribed for Type 1 Diabetes in the US, including trade name, molecule name, and company
  • Type 1 Diabetes drugs sales: Find out the sales revenues of Type 1 Diabetes drugs in the US
  • Type 1 Diabetes market valuations: Find out the market size for Type 1 Diabetes drugs in 2019 in the US. Find out how the market advanced from 2017 and forecast to 2026
  • Type 1 Diabetes drugs market share: Find out the market shares for key Type 1 Diabetes drugs in the US

Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Type 1 Diabetes market analysis and sales trends
  • Track competitor drugs sales and market share in the US Type 1 Diabetes market
  • Track competitive developments in Type 1 Diabetes market and present key issues and learnings
  • Synthesize insights for Type 1 Diabetes market and products to drive business performance
  • Answer key business questions about the Type 1 Diabetes market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Type 1 Diabetes products
  • Supports decision making in R&D to long term marketing strategies


This product will be delivered within 2 business days.

Table of Contents

1) Type 1 Diabetes Treatments
2) Type 1 Diabetes Pipeline
3) US Type 1 Diabetes Epidemiology
4) Marketed Drugs for Type 1 Diabetes in US
5) US Type 1 Diabetes Market Size and Forecast
6) US Type 1 Diabetes Products Sales and Forecast
7) US Type 1 Diabetes Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Type 1 Diabetes Phase 3 Clinical Trials, 2021
2. Type 1 Diabetes Phase 2 Clinical Trials, 2021
3. Type 1 Diabetes Phase 1 Clinical Trials, 2021
4. Type 1 Diabetes Epidemiology, US, 2017 – 2026
5. Marketed Drugs for Type 1 Diabetes, US, 2020
6. Type 1 Diabetes Market Size and Forecast ($), US, 2017 – 2026
7. Type 1 Diabetes Product Sales ($), US, 2017 – 2026

List of Figures
1. Type 1 Diabetes Epidemiology, US, 2017 – 2026
2. Type 1 Diabetes Market Size and Forecast ($), US, 2017 – 2026
3. Type 1 Diabetes Products Market Share (%), US, 2019

Countries Covered

  • US